Showing results (1-10 of 520) with videos related to
Sort By:
Pageof 52
The Lancet. Neurology|July 10, 2003
Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapyGeoffrey A Donnan, Stephen M DavisCerebrovascular Diseases (Basel, Switzerland)|January 20, 2004
Advances in penumbra imaging with MRStephen M Davis, Geoffrey A DonnanCerebrovascular Diseases (Basel, Switzerland)|November 4, 2021
Ischemic Penumbra: A Personal ViewStephen M Davis, Geoffrey A DonnanStroke|March 22, 2003
Recommendations for the relationship between sponsors and investigators in the design and conduct of clinical stroke trialsGeoffrey A Donnan, Stephen M Davis, Markku Kaste, et al.Current Opinion in Neurology|January 25, 2003
The role of blood pressure lowering before and after strokeGeoffrey A Donnan, Stephen M Davis, Amanda ThriftThe Medical Journal of Australia|November 21, 2007
Tissue plasminogen activator for ischaemic stroke: highly effective, reasonably safe and grossly underusedStephen M Davis, Peter J Hand, Geoffrey A DonnanInternational Journal of Stroke : Official Journal of the International Stroke Society|June 21, 2013
How much diffusion lesion reversal occurs after treatment within three-hours of stroke onset?Bruce C V Campbell, Stephen M Davis, Geoffrey A DonnanThe Lancet. Neurology|February 24, 2009
Penumbral selection of patients for trials of acute stroke therapyGeoffrey A Donnan, Jean-Claude Baron, Henry Ma, et al.Current Treatment Options in Cardiovascular Medicine|June 5, 2003
Aortic Source of Brain EmbolismGeoffrey A. Donnan, Stephen M. Davis, Elizabeth F. Jones, et al.Pageof 52